{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1010000781990306049.json","@type":"Article","resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"ja","@value":"ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer"}],"publication":{"prism:publicationName":[{"@language":"ja","@value":"Lung Cancer 59"}],"prism:publicationDate":"2008","prism:startingPage":"377","prism:endingPage":"384"},"reviewed":"true","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781990306048","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"18790993"},{"@type":"JGN","@value":"JP18790993"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18790993/"}],"notation":[{"@language":"ja","@value":"肺癌の個別化治療を目指した遺伝子異常と分子標的治療薬の効果に関する検討"}]}],"dataSourceIdentifier":[{"@type":"KAKEN","@value":"PRODUCT-11300127"}]}